Monkey, rat, and chicken tracheal epithelial cells, as well as monkey, rat, guinea pig, and chicken erythrocytes, adsorbed firmly to colonies of Mycoplasma pneumoniae and M. gallisepticum. Colonies of M. pulmonis also adsorbed erythrocytes but with less avidity than M. pneumoniae or M. gallisepticum; unlike the latter organisms, M. pulmonis did not adsorb tracheal epithelial cells. Colonies of M. orale type 1 and M. orale type 3 adsorbed only chicken red cells. Other mycoplasma species tested, including four of human origin and one of animal origin, did not adsorb red cells or epithelial cells. M. pneumoniae and M. gallisepticum appeared to attach to erythrocytes or tracheal epithelial cells by neuraminic acid receptors on these cells, whereas M. orale types 1 and 3 and M. pulmonis seemed to utilize another type or other types of receptors. Pretreatment of red cells or tracheal epithelial cells with receptor-destroying enzyme, neuraminidase, or influenza B virus removed the adsorption receptors for M. pneumoniae. Similarly, pretreatment of M. pneumoniae colonies with neuraminic acid-containing materials prevented adsorption of erythrocytes or respiratory tract cells. The adsorption sites on M. pneumoniae were specifically blocked by homologous but not heterologous antisera. This property made it possible to study the nature of the mycoplasma adsorption sites by testing the capacity of different fractions of the organism to block the action of adsorptioninhibiting antibodies. Such studies suggested that the mycoplasma binding sites were probably lipid or lipoprotein in nature. The glycerophospholipid hapten was implicated as one such site, since this serologically active hapten blocked the action of hemadsorption-inhibiting antibodies in M. pneumoniae rabbit antiserum. The affinity of M. pneumoniae for respiratory tract epithelium, unique among the mycoplasmas that infect man, may play a role in virulence, since this type of attachment provides an unusual opportunity for peroxide, secreted by the organism, to attack the tissue cell membrane without being rapidly destroyed by catalase or peroxidase present in extracellular body fluids.
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Mycoplasma pneumoniae is the most virulent of the mycoplasmas that infect man (3) . It has been suggested that its virulence is due, in part, to a peroxide hemolysin secreted by this organism (7, 16) . Non-M. pneumoniae mycoplasmas of man, except for the "T" strains, also generated such a peroxide hemolysin; however, the extent of peroxide secretion by these organisms was less than that of M. pneumoniae. Since nonpathogenic mycoplasmas secrete peroxide, it would appear that one determinant of virulence of M. pneumoniae is more likely the amount of peroxide 1 Visiting Scientist from the Institute of Epidemiology and Microbiology, Prague, Czechoslovakia. secreted rather than peroxide generation per se (Sobeslavsky and Chanock, in press ).
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know whether M. pneumoniae could also adsorb to cells of other tissues, namely, those of the respiratory tract, and if so, whether other mycoplasmas of man possess the same capacity. Such information would have relevance to the pathogenesis of respiratory disease caused by M. pneumoniae. In addition, we were interested in defining the nature of the adsorption mechanism of those mycoplasmas which attach to host cells.
MATERIALS AND METHODS
Organisms. Seven species of mycoplasmas which infect man and three species of mycoplasmas which infect animals were studied. All strains employed were subjected to multiple passages in mycoplasma media and were cloned three times prior to use in this study. cells/ml) was mixed with one volume of the reagent to be tested, and the mixture was incubated, with occasional shaking, at 37 C. After 30 min of incubation, the cells were washed and resuspended to original volume in saline. Treated cells (0.5 ml) were then pipetted onto the agar surface which contained mycoplasma colonies. RDE and neuraminidase were diluted in calcium acetate saline (CAS), pH 6.2 (1), whereas the other reagents were diluted in phosphatebuffered saline (PBS), pH 7.2.
The nature of adsorption receptors on M. pneumoniae was examined by exposing colonies to the following reagents (0.5 ml volume) or conditions:
heat, 56 C for 1 to 4 min; ultraviolet light (General Electric G-30T8, 30 w), 44 ,w/cm2 at room temperature for 2 to Twofold dilutions (0.5 ml) of immune sera in PBS were applied to M. pneumoniae colonies on agar, and the cultures were incubated for 1 hr at 37 C. The cultures were then washed once with saline, and 0.5 ml of a 0.5% suspension of guinea pig red blood cells or 0.5 ml of tracheal epithelial cells (100,000 cells/ml) was applied to the agar surface.
Gel filtration of immune sera. To identify the immunoglobulins responsible for hemadsorption inhibition, hyperimmune rabbit, guinea pig, and mule M. pneumoniae antisera were subjected to gel filtration using Sephadex G-200 gel (Pharmacia, Inc., New Market, N.J.). A 3-ml sample of serum was applied to a column 700 mm in length and 20 mm in width, and eluates were collected in 3-ml volumes as described elsewhere (2) . Protein concentrations of eluates from Sephadex chromatogram were determined by the Lowry method (10). The eluates containing 19S or 7S globulins were pooled, dialyzed, lyophilized, and reconstituted to the original volume of the serum. Fractionation of the sera was kindly performed by Joseph Bellanti. Chemical extraction and chromatographic separation of fractions of M. pneumoniae. Purified suspensions of M. pneumoniae were prepared from organisms grown on a glass surface. Prior to their removal from the glass surface, the organisms were washed extensively to remove constituents of the growth medium (15) . To determine which components of M. pneumoniae were involved in the adsorption reaction, fractions of the organism were prepared by chemical and chromatographic separation described previously (12 The total lipid that was chemically extracted from M. pneumoniae and which comprised approximately 20% of the organism by weight was further fractionated on a silicic acid column by a method described previously (13) . The fractions eluted from the silicic acid column with benzene-hexane (6:94, 1:4, or 6:4), benzene, CHCl3-benzene (3:1), CHCl3, CHCl3-CH30H (20:1, 9:1, 4:1, 1:1, or 1:20), or ether were dried in vacuo, taken up in a small volume of propylene glycol, and suspended in isotonic saline to a concentration of 0.1% by weight. The fraction which was eluted from the column with a 9:1 mixture of CHC13-CH30H possessed both high-complementfixing activity and metabolism-inhibiting antibody blocking activity, whereas the other fractions were without either activity (11) . This active material appeared to be a phospholipid which contained saturated and unsaturated fatty acids linked to glycerol by ester bonds. In addition, it was free of detectable sugars and nitrogen (Prescott, Chernick, and Chanock, unpublished data). When inoculated into animals, the glycerophospholipid failed to stimulate antibody and thus appeared to be a hapten.
Test of inhibitioni of hemadsorption inhibition. This test was devised to measure the capacity of M. pneumoniae or its fractions to block hemadsorptioninhibiting antibodies by combining with such antibodies. Various concentrations of M. pneumoniae or fractions of this organism (0.25-ml volume) were mixed with an equal volume of M. pneumoniae antiserum diluted to contain 8, 4, 2, or 1 unit of hemadsorption-inhibiting antibody. Serum dilutions mixed with a suspension of M. gallisepticum or M. fermentans served as controls. The mixtures were incubated with occasional shaking for 1 hr at 37 C and applied to M. pneumoniae colonies growing on agar medium. Subsequently, these agar plates were incubated at 37 C for 1 hr, then washed with saline, and 0.5 ml of a 0.5% suspension of guinea pig red cells or 0.5 ml of tracheal epithelial cells (100,000/ml) in saline was applied to the colonies. A blocking effect was considered significant when the test material blocked the inhibitory effect of 4 to 8 units of hemadsorptioninhibiting antibody.
Complement fixation and inhibition of metabolisminhibiting antibody tests. The M. pneumoniae suspensions and fractions which were tested for hemadsorption inhibition blocking activity were also tested for both complement-fixing activity and metabolisminhibiting antibody blocking activity by methods described previously (14) .
Immunization of animals with M. pneumonziae fractions. Antisera to the fractions of M. pneumoniae were prepared in rabbits and guinea pigs according to immunization methods described previously (14) .
RESULTS
Adsorption of erythrocytes or epithelial cells to mycoplasma colonies. Results of adsorption experiments are summarized in Table 1 . Guinea pig, monkey, rat, or chicken erythrocytes adsorbed to colonies of M. pneumoniae or M. gallisepticum (Fig. 1) . Epithelial cells from monkey, rat, or chicken trachea, as well as monkey kidney cells, were adsorbed in a similar fashion (Fig. 2) (5-7) . The disruptive effect of peroxide upon the host cell could well be magnified if it acted directly upon the cell membrane rather than after diffusion through and dilution in extracellular fluids.
Although the adsorption reaction between M. pneumoniae and respiratory epithelial cells may explain, in part, the virulence of the organism, the experimental findings fail to explain the natural host specificity of M. pneumoniae, since the organism exhibited firm binding not only to primate tracheal epithelium but also to epithelial cells from the rat and the chicken trachea. Thus far, M. pneumoniae has not been recovered from rats or chickens under natural conditions. In contrast, under experimental conditions, both of these species can be infected with M. pneumoniae that localizes in the lower respiratory tract, producing pneumonitis in rats and a silent infection in chick embryos (8) .
The red cell and tracheal epithelial cell receptor was apparently neuraminic acid, since it was removed by treatment of cells with RDE, purified neuraminidase, or influenza B virus. In addition, pretreatmrent of M. pneumoniae with neuraminic acid or neuraminelactose prevented adsorption of erythrocytes or respiratory tract cells. It is of interest that M. gallisepticum, which is a respiratory tract pathogen of birds, attaches to similar receptors on red cells (9) and on respiratory epithelial cells. The other mycoplasmas tested differed in either (i) failing to adsorb to cells or (ii) adsorbing to cells through non-RDE sensitive receptors.
The adsorption sites on M. pneumoniae were specifically blocked by homologous but not heterologous antisera. This property made it possible to study the nature of the mycoplasma adsorption sites by testing the capacity of different fractions of the organism to block the action of hemadsorption-inhibiting antibodies. Antibodies of this type in rabbit antisera were blocked by the lipid extract of M. pneumoniae and by the glycerophospholipid hapten of the organism but not by protein or polysaccharide fractions. This indicates that the glycerophospholipid hapten, which is the serologically active component primarily responsible for reaction with complement-fixing antibodies in all antisera and metabolism-inhibiting antibodies in human and rabbit antisera, was also involved in the adsorption reaction with tissue cells (11) . A component of M. pneumoniae other than the glycerophospholipid hapten also appeared to be involved, since the hemadsorption inhibition activity of guinea pig and mule antisera was not blocked by the lipid extract of the organism nor by the hapten. Unlike the glycerophospholipid hapten, the other active component was not heat stable, since exposure of M. pneumoniae to 56 C for 30 min abolished its blocking activity for hemadsorption-inhibiting antibodies in guinea pig and mule sera. The nature of this additional component was not defined; however, the finding that Sephadex G-25 fraction 1 (rich in lipoprotein) inhibited hemadsorption-inhibiting antibodies in mule and guinea pig antisera suggested that the component may be lipoprotein or a constituent of lipoprotein.
